SPY315.89-1.16 -0.37%
DIA260.71-2.29 -0.87%
IXIC10,433.53-0.12 0.00%

Halozyme To Receive $10M Milestone Payment From Janssen

SAN DIEGO, June 22, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) today announced  the company will receive a $10 million milestone payment from Janssen Biotech, Inc. (Janssen) triggered under the

Benzinga · -

SAN DIEGO, June 22, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) today announced  the company will receive a $10 million milestone payment from Janssen Biotech, Inc. (Janssen) triggered under the Collaboration and License Agreement between the two companies. The milestone payment is associated with the first commercial sale in the European Union of Janssen's subcutaneous formulation of DARZALEX® (daratumumab) utilizing ENHANZE®, which was recently granted marketing authorization by the European Commission.